The FDA will conduct a national survey of 500 nurse practitioners, 500 physician assistants and 1,000 physicians about direct-to-consumer advertising for prescription medicines, according to a notice to be published in the Federal Register. A previous survey found differences in opinions among providers on how ads influence clinical practice.

Related Summaries